RELAY THERAPEUTICS INC (RLAY)

US75943R1023 - Common Stock

6.8  +0.14 (+2.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
25.55M1.38M3.03M82.65M0.00
Operating Expenses
398.55M300.66M355.87M138.45M84.05M
Research and Development
330.02M246.36M292.53M96.97M70.31M
Selling, General, and Administrative Expenses
74.95M65.98M57.39M38.59M13.74M
Operating Income
-373.00M-299.28M-352.84M-55.80M-84.05M
Interest Income/Expense
31.05M8.79M-11.03M3.40M8.80M
Other Income/Expense
-18.00K-20.00K0.00-20.00K-60.00K
Income Before Taxes
-341.97M-290.51M-363.87M-52.41M-75.31M
Net Income
-341.97M-290.51M-363.87M-230.20M-75.31M
EBITDA
-367.73M-295.15M-348.91M-52.25M-81.20M
 
Per Share Data
EPS Diluted Total Ops
-2.79-2.59-3.82-2.56-0.87
Non GAAP EPS
-2.80-2.60-3.85N/AN/A
 
Statistics
Profit Margin
-1338.66%-21051.45%-12008.91%-278.52%N/A
Operating Profit Margin
-1460.11%-21686.96%-11644.88%-67.51%N/A

All data in USD

Charts